indacaterol Articles

Novartis QVA149 Ph III COPD studies meet primary endpoints

2 April 2012

US FDA delays decision on Novartis COPD drug candidate indacaterol

24 March 2011

Datamonitor analysts view MRSA drug prospects for Pharma; Novartis COPD indacaterol

10 March 2011

Novartis COPD drug indacaterol gets mixed message from FDA advisory committee

9 March 2011

Showing 1-4 of 4 articles

Go to beginningPrevious
  • 1
NextGo to end